Cow Colostrum Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

According to a recent market study by Future Market Insights (FMI), the global cow colostrum market is projected to display a CAGR of over 6% during the forecast period from 2021 – 3031. According to a field survey conducted by ColoPlus AB, the use of colostrum in medical nutritional food boosts the immune system of children diagnosed with acquired immune deficiency syndrome (HIV/AIDS), as well as lowers the risk of diarrhea and immune deficiency-related diseases.

In terms of improving immune response, the consumption of important nutrients and supplements, is key especially for pregnant women and patients with ailments such as diabetes. These nutrition-packed foods are available through prescriptions from doctors, physicians, and health professionals.

IgM (Immunoglobulin-M), IgA (Immunoglobulin-A), and IgG (Immunoglobulin-G) are prominent immunoglobulins found in colostrum, with Immunoglobulin-G being the most common variant that breaks down or eliminates infections in the bloodstream. The level of IgG in cow colostrum is around 20% higher than that of human colostrum.

The nutritional profile of cow colostrum qualifies it as an “Ancient Food for Modern Times,” and it is thus categorized as a nutraceutical. Local immunity, athletic performance, permeability, mucosal integrity, systemic immunity, and antigen processing are just a few of the applications for colostrum.

Supplements with cow colostrum can help with autoimmune diseases like rheumatoid arthritis. Due to the inclusion of growth factors, it has potential as an immune modulator for growth supplements aimed towards children.

For more insights into the market, request a sample of this report@https://www.futuremarketinsights.com/reports/sample/rep-gb-13242

Immunoglobulin-G offers passive immunity to the human body, protecting it from viral and bacterial infections and illnesses. Over the projected period, this is expected to drive the worldwide cow colostrum market.

cow colostrum market price benchmark for key regions by segments, 2021

Cow Colostrum Market by Category

On the basis of Nature

  • Organic
  • Conventional

On the basis of Product Type

  • Whole
    • Whole Colostrum Powder
    • Skim Colostrum Powder
    • Specialty Colostrum Powder
  • Colostrum Finished Products
    • Capsules
    • Chewable Tablets
    • Individual Sachets
    • Specially Formulated Products

On the basis of End Use

  • B2B
    • Dietary Supplements
    • Sports Nutrition
    • Functional Foods
    • Animal Nutrition
    • Cosmetics
    • Infant Formula
    • Pharmaceuticals
  • B2C
    • Store Based Retail
      • Hypermarket/Supermarket
      • Convenience Store
      • Specialty Stores
      • Drug Stores
      • Health & Wellness Stores
      • Others
    • Online Retailing

On the basis of Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-13242

Key Questions from Report

  • Who is the Leading End User of Cow Colostrum?

    Cow colostrum is mostly used in the B2B industry, among which functional food is expected to hold the leading share of 37.8% in terms of value in the year 2021.

  • What Type of Cow Colostrum Product is Top-selling?

    Conventional cow colostrum products outpace organic alternatives and are expected to reach a valuation of more than US$ 2.1 Bn in 2021. This can be attributed to easy access and low costs of associated raw materials.

  • Which is the most lucrative market for cow colostrum?

    Currently, the U.S. holds the largest share in the cow colostrum market in terms of value and volume. The U.S. will account for over 61% of the North America market in 2021, driven by rising functional food applications.

  • Which are some of the leading companies offering cow colostrum?

    Some of the leading companies offering cow colostrum products are Colostrum BioTec GmbH, Zuche Pharmaceuticals, Biodane Pharma A/S, Agati Healthcare Pvt. Ltd., McePharma, Cure Nutraceuticals Pvt. Ltd., Ingredia Nutritional (Ingredia S.A.), Sterling Technology, Biotaris B.V., La Belle Inc., Now Health Group, Inc., The Saskatoon Colostrum Company, Good Health New Zealand, and others. Lower tier players are expected to account for around 75% of the overall market share.

Posted on

Leave a Reply

Your email address will not be published. Required fields are marked *